Tag Archives: AZD6765

AstraZeneca: Good News, Bad News (revised)

(Correction in paragraph 3, regarding Targacept): The press coverage today was all about AZ’s decision to advance their BACEi for Alzheimer’s, AZD3293, into a Phase II/III trial that, if highly successful, could in theory serve as a single trial for … Continue reading

Posted in Big Pharma | Tagged , , , | Leave a comment